BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saunte DML, Jemec GBE. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA. 2017;318:2019-2032. [PMID: 29183082 DOI: 10.1001/jama.2017.16691] [Cited by in Crossref: 145] [Cited by in F6Publishing: 81] [Article Influence: 36.3] [Reference Citation Analysis]
Number Citing Articles
1 Frew JW, Navrazhina K, Byrd AS, Garg A, Ingram JR, Kirby JS, Lowes MA, Naik H, Piguet V, Prens EP. Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies. Br J Dermatol 2019;181:1339-41. [PMID: 31269228 DOI: 10.1111/bjd.18309] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
2 Cao Y, Hong F, Conlon DM, Sidur L, Smith KM, Fang Y, Cuff CA, Kaymakcalan Z, Ruzek MC. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol 2021. [PMID: 33811319 DOI: 10.1111/bjd.20097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Huang CM, Kirchhof MG. Hidradenitis Suppurativa From a Patient Perspective Including Symptoms and Self-Treatment. J Cutan Med Surg 2021;:12034754211024157. [PMID: 34137667 DOI: 10.1177/12034754211024157] [Reference Citation Analysis]
4 Lu JW, Huang YW, Chen TL. Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100:e26190. [PMID: 34087885 DOI: 10.1097/MD.0000000000026190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Greydanus DE, Azmeh R, Cabral MD, Dickson CA, Patel DR. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life. Dis Mon 2021;67:101103. [PMID: 33041056 DOI: 10.1016/j.disamonth.2020.101103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 56.0] [Reference Citation Analysis]
7 Hu Y, Zhu Y, Lian N, Chen M, Bartke A, Yuan R. Metabolic Syndrome and Skin Diseases. Front Endocrinol (Lausanne) 2019;10:788. [PMID: 31824416 DOI: 10.3389/fendo.2019.00788] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
8 Racanelli E, Jfri A, Gefri A, O'Brien E, Litvinov IV, Zubarev A, Savin E, Netchiporouk E. Cutaneous Squamous Cell Carcinoma in Patients with Hidradenitis Suppurativa. Cancers (Basel) 2021;13:1153. [PMID: 33800250 DOI: 10.3390/cancers13051153] [Reference Citation Analysis]
9 Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis 2019;10:2040622319830646. [PMID: 30854183 DOI: 10.1177/2040622319830646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
10 Constantinou CA, Fragoulis GE, Nikiphorou E. Hidradenitis suppurativa: infection, autoimmunity, or both? Ther Adv Musculoskelet Dis 2019;11:1759720X19895488. [PMID: 31908656 DOI: 10.1177/1759720X19895488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol 2019;10:2847. [PMID: 31849996 DOI: 10.3389/fimmu.2019.02847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 26.0] [Reference Citation Analysis]
12 Lowe MM, Naik HB, Clancy S, Pauli M, Smith KM, Bi Y, Dunstan R, Gudjonsson JE, Paul M, Harris H, Kim E, Shin US, Ahn R, Liao W, Hansen SL, Rosenblum MD. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy. JCI Insight 2020;5:139932. [PMID: 32841223 DOI: 10.1172/jci.insight.139932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
13 Savage KT, Flood KS, Porter ML, Kimball AB. TNF-α inhibitors in the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis 2019;10:2040622319851640. [PMID: 31191873 DOI: 10.1177/2040622319851640] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
14 Wollina U, Brzezinski P, Koch A, Philipp-Dormston WG. Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa/acne inversa-A narrative review. Dermatol Ther 2020;33:e13877. [PMID: 32558202 DOI: 10.1111/dth.13877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Navrazhina K, Frew JW, Gilleaudeau P, Sullivan-Whalen M, Garcet S, Krueger JG. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol 2021;147:2213-24. [PMID: 33548397 DOI: 10.1016/j.jaci.2020.12.651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
16 Kottner J, Schmitt J. Core outcome sets in dermatology: next steps. Br J Dermatol 2018;179:549-50. [DOI: 10.1111/bjd.16812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fania L, Clemente A, Sampogna F, Mazzanti C, Pallotta S, Panebianco A, Sordi D, Caggiati A, Cassotta G, Tiezzi A, Cristiano L, Zecchi V, Napolitano M, Abeni D. Intralesional ultrasound‐guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: A pilot study. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Navrazhina K, Garcet S, Zheng X, Hur HB, Frew JW, Krueger JG. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression. J Allergy Clin Immunol 2021:S0091-6749(21)00832-0. [PMID: 34081946 DOI: 10.1016/j.jaci.2021.05.027] [Reference Citation Analysis]
19 Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol 2021;39:240-7. [PMID: 34272017 DOI: 10.1016/j.clindermatol.2020.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study. Int J Dermatol 2021. [PMID: 33998670 DOI: 10.1111/ijd.15578] [Reference Citation Analysis]
21 Tugnoli S, Agnoli C, Silvestri A, Giari S, Bettoli V, Caracciolo S. Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa. J Clin Psychol Med Settings 2020;27:527-40. [DOI: 10.1007/s10880-019-09640-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Tzanetakou V, Stergianou D, Giamarellos-Bourboulis EJ. Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa. Expert Opin Drug Saf 2020;19:381-93. [PMID: 32098513 DOI: 10.1080/14740338.2020.1734560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Nomura T. Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease. Front Immunol 2020;11:847. [PMID: 32508815 DOI: 10.3389/fimmu.2020.00847] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
24 Dahmen RA, Gkalpakiotis S, Mardesicova L, Arenberger P, Arenbergerova M. Deroofing mit anschließender sorgfältiger Sinustrakt-Exzision: ein modifizierter chirurgischer Ansatz bei Hidradenitis suppurativa. J Dtsch Dermatol Ges 2019;17:698-702. [PMID: 31364289 DOI: 10.1111/ddg.13875_g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol 2020;16:1019-37. [PMID: 32896186 DOI: 10.1080/17425255.2020.1810233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kridin K, Amber KT, Comaneshter D, Cohen AD. Amyloidosis in hidradenitis suppurativa: a cross‐sectional study and review of the literature. Clin Exp Dermatol 2020;45:565-71. [DOI: 10.1111/ced.14186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Fletcher JM, Moran B, Petrasca A, Smith CM. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol 2020;201:121-34. [PMID: 32379344 DOI: 10.1111/cei.13449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
28 Derruau S, Gobinet C, Untereiner V, Sockalingum GD, Nassif A, Viguier M, Piot O, Lorimier S. New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study. J Biophotonics 2021;14:e202000327. [PMID: 33231348 DOI: 10.1002/jbio.202000327] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Taylor EM, Hamaguchi R, Kramer KM, Kimball AB, Orgill DP. Plastic Surgical Management of Hidradenitis Suppurativa. Plast Reconstr Surg 2021;147:479-91. [PMID: 33620946 DOI: 10.1097/PRS.0000000000007677] [Reference Citation Analysis]
30 Westerkam LL, Tackett KJ, Sayed CJ. Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa. JAMA Dermatol 2021;157:708-11. [PMID: 33825849 DOI: 10.1001/jamadermatol.2021.0220] [Reference Citation Analysis]
31 Posso-De Los Rios CJ, Sarfo A, Ghias M, Alhusayen R, Hamzavi I, Lowes MA, Alavi A. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Exp Dermatol 2019;28:769-75. [PMID: 30924968 DOI: 10.1111/exd.13928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Shanmugam VK, Jones D, Mcnish S, Bendall ML, Crandall KA. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Dermatol 2019;44:882-92. [DOI: 10.1111/ced.13959] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
33 Schell SL, Schneider AM, Nelson AM. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa. Exp Dermatol 2021. [PMID: 34018644 DOI: 10.1111/exd.14398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Dunstan RW, Salte KM, Todorović V, Lowe M, Wetter JB, Harms PW, Burney RE, Scott VE, Smith KM, Rosenblum MD, Gudjonsson JE, Honore P. Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention. Exp Dermatol 2021;30:820-30. [PMID: 33377546 DOI: 10.1111/exd.14273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
35 Derruau S, Renard Y, Pron H, Taiar R, Abdi E, Polidori G, Lorimier S. Combining Magnetic Resonance Imaging (MRI) and Medical Infrared Thermography (MIT) in the pre- and peri-operating management of severe Hidradenitis Suppurativa (HS). Photodiagnosis and Photodynamic Therapy 2018;23:9-11. [DOI: 10.1016/j.pdpdt.2018.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
36 Wortsman X, Calderon P, Castro A. Seventy‐MHz Ultrasound Detection of Early Signs Linked to the Severity, Patterns of Keratin Fragmentation, and Mechanisms of Generation of Collections and Tunnels in Hidradenitis Suppurativa. J Ultrasound Med 2020;39:845-57. [DOI: 10.1002/jum.15164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
37 Zhang M, Chen QD, Xu HX, Xu YM, Chen HJ, Yang BL. Association of hidradenitis suppurativa with Crohn's disease. World J Clin Cases 2021;9:3506-16. [PMID: 34046451 DOI: 10.12998/wjcc.v9.i15.3506] [Reference Citation Analysis]
38 Esposito C, Del Conte F, Cerulo M, Coppola V, Esposito G, Ricciardi E, Castagnetti M, Fabbrocini G, Escolino M. Pediatric Endoscopic Hidradenitis Treatment: A New Minimally Invasive Treatment for Pediatric Patients with Hidradenitis Suppurativa. J Laparoendosc Adv Surg Tech A 2020;30:464-70. [PMID: 32017645 DOI: 10.1089/lap.2019.0614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Teng Y, Tao X, Lu W, Huang Y, Xu D, Li M, Fan Y. Identification of Hidradenitis Suppurativa-Related mRNA Expression Patterns Through Analysis of Gene Expression Omnibus. Dose Response 2020;18:1559325820942646. [PMID: 32782449 DOI: 10.1177/1559325820942646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chaffin AE, Buckley M. Extracellular matrix graft for the surgical management of Hurley stage III hidradenitis suppurativa: a pilot case series. J Wound Care 2020;29:624-30. [DOI: 10.12968/jowc.2020.29.11.624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Caposiena Caro RD, Cannizzaro MV, Tartaglia C, Bianchi L. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab. Clin Exp Dermatol 2020;45:438-44. [DOI: 10.1111/ced.14127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
42 Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G, Arnold JD, Sprague J, Nguyen H, Wan S, Atenafu EG, Pope E, Hamilton J, Naik HB, Lara-Corrales I. Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients. JAMA Dermatol 2021;157:385-91. [PMID: 33625473 DOI: 10.1001/jamadermatol.2020.5435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
43 Molnar J, Mallonee CJ, Stanisic D, Homme RP, George AK, Singh M, Tyagi SC. Hidradenitis Suppurativa and 1-Carbon Metabolism: Role of Gut Microbiome, Matrix Metalloproteinases, and Hyperhomocysteinemia. Front Immunol 2020;11:1730. [PMID: 32973741 DOI: 10.3389/fimmu.2020.01730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Matusiak Ł. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol 2020;183:e171-7. [PMID: 29744872 DOI: 10.1111/bjd.16603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
45 Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020;183:999-1010. [PMID: 33048349 DOI: 10.1111/bjd.19556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
46 Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD, Jemec GBE. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. PLoS One 2018;13:e0200683. [PMID: 30040827 DOI: 10.1371/journal.pone.0200683] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
47 Jørgensen AR, Aarestrup J, Baker JL, Thomsen SF. Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa. JAMA Dermatol 2020;156:746-53. [PMID: 32347905 DOI: 10.1001/jamadermatol.2020.1047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
48 Micieli R, Alavi A. Lymphedema in patients with hidradenitis suppurativa: a systematic review of published literature. Int J Dermatol 2018;57:1471-80. [PMID: 30105858 DOI: 10.1111/ijd.14173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
49 Grand D, Frew JW, Navrazhina K, Krueger JG. Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity. Br J Dermatol 2021;184:688-96. [PMID: 32602132 DOI: 10.1111/bjd.19343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
50 Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ, Shyu YC, Firth J, Koyanagi A, Solmi M, Alavi A, Piguet V, Carvalho AF. Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. JAMA Dermatol 2019;155:939-45. [PMID: 31166590 DOI: 10.1001/jamadermatol.2019.0759] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
51 Gargallo-Benedicto A, Clemente-Tomás R, Pastor-Espuig M, Ballano-Ruiz A, Garzarán-Teijeiro A, Alias-Alegre E, Navarro-Casado MN. Bilateral Phlyctenular Keratoconjunctivitis in the Context of Hidradenitis Suppurativa: A Case Report and Literature Review. Ocul Immunol Inflamm 2020;:1-3. [PMID: 33226311 DOI: 10.1080/09273948.2020.1833223] [Reference Citation Analysis]
52 Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Front Immunol. 2018;9:2965. [PMID: 30619323 DOI: 10.3389/fimmu.2018.02965] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 18.3] [Reference Citation Analysis]
53 Tzur Bitan D, Berzin D, Cohen A. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study. J Eur Acad Dermatol Venereol 2019;34:574-9. [DOI: 10.1111/jdv.15997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
54 Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm. Front Med (Lausanne) 2020;7:68. [PMID: 32195261 DOI: 10.3389/fmed.2020.00068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
55 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
56 Naik HB. Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care. JAMA Dermatol 2021;157:381-3. [PMID: 33688911 DOI: 10.1001/jamadermatol.2020.5466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Barrea L, Fabbrocini G, Annunziata G, Muscogiuri G, Donnarumma M, Marasca C, Colao A, Savastano S. Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease. Nutrients 2018;11:E57. [PMID: 30597889 DOI: 10.3390/nu11010057] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 11.7] [Reference Citation Analysis]
58 Gergely LH, Gáspár K, Brodszky V, Kinyó Á, Szegedi A, Remenyik É, Kiss NF, Bató A, Péntek M, Gulácsi L, Sárdy M, Bánvölgyi A, Wikonkál N, Rencz F. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020;34:2584-92. [PMID: 32618022 DOI: 10.1111/jdv.16642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
59 de Haan JB, Hernandez N, Sen S. Erector spinae block for postoperative analgesia following axillary hidradenitis suppurativa resection: a case report. Local Reg Anesth 2018;11:87-90. [PMID: 30532584 DOI: 10.2147/LRA.S179830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
60 Licata G, Gambardella A, Buononato D, De Rosa A, Calabrese G, Pellerone S, Argenziano G. A case of moderate hidradenitis suppurativa and psoriasis successfully treated with risankizumab. Int J Dermatol 2021. [PMID: 34151438 DOI: 10.1111/ijd.15704] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li Y, Li T, Chen L, Zhang L. Patient satisfaction and quality of life after surgery combined with 5-aminolevulinic acid-based photodynamic therapy for hidradenitis suppurativa. J Am Acad Dermatol 2021:S0190-9622(21)00140-7. [PMID: 33440214 DOI: 10.1016/j.jaad.2020.09.098] [Reference Citation Analysis]
62 Muralidharan V, Pathmarajah P, Peterknecht E, Qazi E, Barlow R, Muralidharan V, Abdullah A, McDonald B, Bewley A. Real life data on the biopsychosocial effects of Adalimumab in the management of hidradenitis suppurativa: A multicenter cross sectional analysis and consideration of a multisystem monitoring approach to follow up. Dermatol Ther 2021;34:e14643. [PMID: 33296539 DOI: 10.1111/dth.14643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 Zouboulis CC, Nogueira da Costa A, Makrantonaki E, Hou XX, Almansouri D, Dudley JT, Edwards H, Readhead B, Balthasar O, Jemec GBE, Bonitsis NG, Nikolakis G, Trebing D, Zouboulis KC, Hossini AM. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020;34:846-61. [PMID: 31838778 DOI: 10.1111/jdv.16147] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
64 Liu M, Degner J, Georgantas RW, Nader A, Mostafa NM, Teixeira HD, Williams DA, Kirsner RS, Nichols AJ, Davis JW, Waring JF. A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2. Journal of Investigative Dermatology 2020;140:574-582.e2. [DOI: 10.1016/j.jid.2019.06.152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
65 Vossen ARJV, van Huijkelom MAPC, Nijsten TEC, Bakker EWP, van der Zee HH, van Doorn MBA, Prens EP. Aggravation of mild axillary hidradenitis suppurativa by microwave ablation: Results of a randomized intrapatient-controlled trial. J Am Acad Dermatol 2019;80:777-9. [PMID: 29940205 DOI: 10.1016/j.jaad.2018.06.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
66 Isoherranen K, O'brien JJ, Barker J, Dissemond J, Hafner J, Jemec GBE, Kamarachev J, Läuchli S, Montero EC, Nobbe S, Sunderkötter C, Velasco ML. Atypical wounds. Best clinical practice and challenges. J Wound Care 2019;28:S1-S92. [DOI: 10.12968/jowc.2019.28.sup6.s1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
67 Morita A, Takahashi H, Ozawa K, Imafuku S, Nakama T, Takahashi K, Matsuyama T, Okubo Y, Kitamura S, Matsuda N, Zhao Y, Yokoyama M, Hayashi N, Terui T. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. J Dermatol 2019;46:745-51. [PMID: 31282051 DOI: 10.1111/1346-8138.14997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
68 Frew JW, Navrazhina K. In silico Analysis of Gamma-Secretase-Complex Mutations in Hidradenitis Suppurativa Demonstrates Disease-Specific Substrate Recognition and Cleavage Alterations. Front Med (Lausanne) 2019;6:206. [PMID: 31608281 DOI: 10.3389/fmed.2019.00206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Fajgenbaum K, Crouse L, Dong L, Zeng D, Sayed C. Intralesional Triamcinolone May Not Be Beneficial for Treating Acute Hidradenitis Suppurativa Lesions: A Double-Blind, Randomized, Placebo-Controlled Trial. Dermatol Surg 2020;46:685-9. [PMID: 31490300 DOI: 10.1097/DSS.0000000000002112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
70 Matusiak Ł, Jemec GB, Szepietowski JC. Pharmacological development in hidradenitis suppurativa. Current Opinion in Pharmacology 2019;46:65-72. [DOI: 10.1016/j.coph.2019.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
71 Savage KT, Brant EG, Rosales Santillan M, Morss PC, Salian P, Flood KS, Porter ML, Kimball AB. Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa. Int J Womens Dermatol 2020;6:159-63. [PMID: 32637536 DOI: 10.1016/j.ijwd.2020.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
72 Penno CA, Jäger P, Laguerre C, Hasler F, Hofmann A, Gass SK, Wettstein-Ling B, Schaefer DJ, Avrameas A, Raulf F, Wieczorek G, Lehmann JCU, Loesche C, Roth L, Röhn TA. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. J Invest Dermatol 2020;140:2421-2432.e10. [PMID: 32387270 DOI: 10.1016/j.jid.2020.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
73 Phan K, Charlton O, Smith SD. Global prevalence of hidradenitis suppurativa and geographical variation—systematic review and meta-analysis. biomed dermatol 2020;4. [DOI: 10.1186/s41702-019-0052-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
74 Prens LM, Huizinga J, Janse IC, Horváth B. Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study. J Eur Acad Dermatol Venereol 2019;33:1941-6. [PMID: 31132177 DOI: 10.1111/jdv.15706] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
75 Frew JW, Jiang CS, Singh N, Grand D, Navrazhina K, Vaughan R, Krueger JG. Dermal tunnels influence time to clinical response and family history influences time to loss of clinical response in patients with hidradenitis suppurativa treated with adalimumab. Clin Exp Dermatol 2021;46:306-13. [PMID: 32931599 DOI: 10.1111/ced.14448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
76 Kjærsgaard Andersen R, Jørgensen IF, Reguant R, Jemec GBE, Brunak S. Disease Trajectories for Hidradenitis Suppurativa in the Danish Population. JAMA Dermatol 2020;156:780-6. [PMID: 32432647 DOI: 10.1001/jamadermatol.2020.1281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
77 Bouazzi D, Chafranska L, Saunte DML, Jemec GBE. Systematic Review of Complications and Recurrences After Surgical Interventions in Hidradenitis Suppurativa. Dermatol Surg 2020;46:914-21. [PMID: 32049703 DOI: 10.1097/DSS.0000000000002323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
78 Elkin K, Daveluy S, Avanaki K(. Hidradenitis suppurativa: Current understanding, diagnostic and surgical challenges, and developments in ultrasound application. Skin Res Technol 2020;26:11-9. [DOI: 10.1111/srt.12759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Anduquia-Garay F, Rodríguez-Gutiérrez MM, Poveda-Castillo IT, Valdes-Moreno PL, Agudelo-Rios DA, Benavides-Moreno JS, Lozada-Martínez ID, Bolaño-Romero MP, Borraez-Segura B, Rahman S. Hidradenitis suppurativa: Basic considerations for its approach: A narrative review. Ann Med Surg (Lond) 2021;68:102679. [PMID: 34401142 DOI: 10.1016/j.amsu.2021.102679] [Reference Citation Analysis]
80 Shukla N, Paul M, Halley M, Lowes MA, Hester V, Aguilar C, Guilbault S, Long TS, Taylor A, Thompson AC, Yannuzzi CA, Linos E, Naik HB. Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event. Br J Dermatol 2020;182:1490-2. [PMID: 31883104 DOI: 10.1111/bjd.18818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
81 Akiyama M. Autoinflammatory Keratinization Diseases (AiKDs): Expansion of Disorders to Be Included. Front Immunol 2020;11:280. [PMID: 32153585 DOI: 10.3389/fimmu.2020.00280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]